Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity

Cancer Biology and Therapy

Volumn 15, Issue 1, 2014, Pages 61-68

  Yang, Lifang ^a,b   Xu, Zhijie ^a   Liu, Liyu ^a   Luo, Xiangjian ^a   Lu, Jingchen ^a   Sun, Lunquan ^b   Cao, Ya ^a  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Akt; DNAzyme; HTERT; LMP1; NPC; Radiosensitivity; Telomerase

Indexed keywords

DNAZYME; LATENT MEMBRANE PROTEIN 1; PROTEIN KINASE INHIBITOR; SMALL INTERFERING RNA; TELOMERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVE SITE; EPSTEIN BARR VIRUS; GENE OVEREXPRESSION; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; RADIOSENSITIZATION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AKT; DNAZYME; HTERT; LMP1; NPC; RADIOSENSITIVITY; TELOMERASE;

CELL LINE, TUMOR; DNA, CATALYTIC; HUMANS; NASOPHARYNGEAL NEOPLASMS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RADIATION TOLERANCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TELOMERASE; VIRAL MATRIX PROTEINS;

EID: 84891800347     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.26606     Document Type: Article

References (33)

1. Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, Zee BC, Law SC, Teo PM, Tung SY, et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2005; 61:1107-16; PMID:15752890; http://dx.doi.org/10.1016/j. ijrobp.2004.07.702 (Pubitemid 40340904)
2. Eliopoulos AG, Young LS. LMP1 structure and signal transduction. Semin Cancer Biol 2001; 11:435-44; PMID:11669605; http://dx.doi.org/10.1006/scbi.2001. 0410 (Pubitemid 33105022)
3. Tsao SW, Tsang CM, Pang PS, Zhang G, Chen H, Lo KW. The biology of EBV infection in human epithelial cells. Semin Cancer Biol 2012; 22:137-43; PMID:22497025; http://dx.doi.org/10.1016/j. semcancer.2012.02.004
4. Meckes DG Jr., Shair KH, Marquitz AR, Kung CP, Edwards RH, Raab-Traub N. Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci U S A 2010; 107:20370-5; PMID:21059916; http://dx.doi.org/10.1073/pnas. 1014194107
5. Zhao Y, Wang Y, Zeng S, Hu X. LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis. J Clin Pathol 2012; 65:41-5; PMID:22039283; http://dx.doi.org/10.1136/jclinpath- 2011-200198
6. Chew MM, Gan SY, Khoo AS, Tan EL. Interleukins, laminin and Epstein-Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma. BMC Cancer 2010; 10:574; PMID:20964870; http://dx.doi.org/10.1186/1471-2407-10-574
7. Shair KH, Schnegg CI, Raab-Traub N. EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. Cancer Res 2008; 68:6997-7005; PMID:18757414; http://dx.doi.org/10.1158/0008-5472.CAN-08-1178
8. Hannigan A, Wilson JB. Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition. Mol Cancer 2010; 9:184; PMID:20618963; http://dx.doi.org/10.1186/1476-4598-9-184
9. Mei YP, Zhou JM, Wang Y, Huang H, Deng R, Feng GK, Zeng YX, Zhu XF. Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells. Cell Cycle 2007; 6:1379-85; PMID:17507800; http://dx.doi.org/ 10.4161/cc.6.11.4274 (Pubitemid 47327973)
10. Li X, Liu X, Li CY, Ding Y, Chau D, Li G, Kung HF, Lin MC, Peng Y. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1. Int J Oncol 2006; 29:595-603; PMID:16865275
11. Dass CR, Choong PF, Khachigian LM. DNAzyme technology and cancer therapy: cleave and let die. Mol Cancer Ther 2008; 7:243-51; PMID:18281510; http://dx.doi.org/10.1158/1535-7163.MCT-07-0510 (Pubitemid 351302518)
12. Lu ZX, Ye M, Yan GR, Li Q, Tang M, Lee LM, Sun LQ, Cao Y. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis. Cancer Gene Ther 2005; 12:647-54; PMID:15803142; http://dx.doi.org/10.1038/sj.cgt.7700833 (Pubitemid 40967225)
13. Wang Z, Luo F, Li L, Yang L, Hu D, Ma X, Lu Z, Sun L, Cao Y. STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. Eur J Cancer 2010; 46:2996-3006; PMID:20709526; http://dx.doi.org/10.1016/j.ejca.2010.07.008
14. Lu ZX, Ma XQ, Yang LF, Wang ZL, Zeng L, Li ZJ, Li XN, Tang M, Yi W, Gong JP, et al. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma. Cancer Lett 2008; 265:226-38; PMID:18353539; http://dx.doi.org/10.1016/j.canlet.2008.02.019
15. Ma X, Yang L, Xiao L, Tang M, Liu L, Li Z, Deng M, Sun L, Cao Y. Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-?B regulated ATM expression. PLoS One 2011; 6:e24647; PMID:22096476; http://dx.doi.org/10.1371/journal.pone.0024647
16. Ayouaz A, Raynaud C, Heride C, Revaud D, Sabatier L. Telomeres: hallmarks of radiosensitivity. Biochimie 2008; 90:60-72; PMID:18006207; http://dx.doi.org/10.1016/j.biochi.2007.09.011 (Pubitemid 350216220)
17. Agarwal M, Pandita S, Hunt CR, Gupta A, Yue X, Khan S, Pandita RK, Pratt D, Shay JW, Taylor JS, et al. Inhibition of telomerase activity enhances hyperthermia-mediated radiosensitization. Cancer Res 2008; 68:3370-8; PMID:18451164; http://dx.doi.org/10.1158/0008-5472.CAN-07-5831
18. Martínez P, Blasco MA. Telomeric and extratelomeric roles for telomerase and the telomerebinding proteins. Nat Rev Cancer 2011; 11:161-76; PMID:21346783; http://dx.doi.org/10.1038/nrc3025
19. Sharma GG, Gupta A, Wang H, Scherthan H, Dhar S, Gandhi V, Iliakis G, Shay JW, Young CS, Pandita TK. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 2003; 22:131-46; PMID:12527915; http://dx.doi.org/10.1038/sj.onc.1206063 (Pubitemid 36152891)
20. Daniel M, Peek GW, Tollefsbol TO. Regulation of the human catalytic subunit of telomerase (hTERT). Gene 2012; 498:135-46; PMID:22381618; http://dx.doi.org/10.1016/j.gene.2012.01.095
21. Chung J, Khadka P, Chung IK. Nuclear import of hTERT requires a bipartite nuclear localization signal and Akt-mediated phosphorylation. J Cell Sci 2012; 125:2684-97; PMID:22366458; http://dx.doi.org/10.1242/jcs.099267
22. Kang SS, Kwon T, Kwon DY, Do SI. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 1999; 274:13085-90; PMID:10224060; http://dx.doi.org/10. 1074/jbc.274.19.13085
23. Kimura A, Ohmichi M, Kawagoe J, Kyo S, Mabuchi S, Takahashi T, Ohshima C, Arimoto-Ishida E, Nishio Y, Inoue M, et al. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 2004; 23:4505-15; PMID:15048073; http://dx.doi.org/10.1038/sj.onc. 1207582 (Pubitemid 38850400)
24. Terrin L, Dal Col J, Rampazzo E, Zancai P, Pedrotti M, Ammirabile G, Bergamin S, Rizzo S, Dolcetti R, De Rossi A. Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes. J Virol 2008; 82:10175-87; PMID:18684838; http://dx.doi.org/10.1128/JVI.00321-08
25. Ding L, Li L, Yang J, Zhou S, Li W, Tang M, Shi Y, Yi W, Cao Y. Latent membrane protein 1 encoded by Epstein-Barr virus induces telomerase activity via p16INK4A/Rb/E2F1 and JNK signaling pathways. J Med Virol 2007; 79:1153-63; PMID:17597480; http://dx.doi.org/10.1002/jmv.20896 (Pubitemid 47015415)
26. Lebel R, McDuff FO, Lavigne P, Grandbois M. Direct visualization of the binding of c-Myc/Max heterodimeric b-HLH-LZ to E-box sequences on the hTERT promoter. Biochemistry 2007; 46:10279-86; PMID:17705400; http://dx.doi.org/10. 1021/bi700076m (Pubitemid 350067621)
27. Ding L, Li LL, Yang J, Tao YG, Ye M, Shi Y, Tang M, Yi W, Li XL, Gong JP, et al. Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factorkappaB p65 in human nasopharyngeal carcinoma cells. Int J Biochem Cell Biol 2005; 37:1881-9; PMID:15967702; http://dx.doi.org/10.1016/j. biocel.2005.04.012 (Pubitemid 40961672)
28. Wesbuer S, Lanvers-Kaminsky C, Duran-Seuberth I, Bölling T, Schäfer KL, Braun Y, Willich N, Greve B. Association of telomerase activity with radioand chemosensitivity of neuroblastomas. Radiat Oncol 2010; 5:66; PMID:20642823; http://dx.doi.org/10.1186/1748-717X-5-66
29. Dong X, Liu A, Zer C, Feng J, Zhen Z, Yang M, Zhong L. siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells. BMC Cancer 2009; 9:133; PMID:19416503; http://dx.doi.org/10.1186/1471- 2407-9-133
30. Li Y, Li M, Yao G, Geng N, Xie Y, Feng Y, Zhang P, Kong X, Xue J, Cheng S, et al. Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma. Cancer Gene Ther 2011; 18:318-25; PMID:21233858; http://dx.doi.org/10.1038/cgt.2010.81
31. Lü MH, Liao ZL, Zhao XY, Fan YH, Lin XL, Fang DC, Guo H, Yang SM. hTERT-based therapy: a universal anticancer approach (Review). Oncol Rep 2012; 28:1945-52; PMID:22992764
32. Cai H, Santiago FS, Prado-Lourenco L, Wang B, Patrikakis M, Davenport MP, Maghzal GJ, Stocker R, Parish CR, Chong BH, et al. DNAzyme targeting c-jun suppresses skin cancer growth. Sci Transl Med 2012; 4:39ra82; PMID:22723462; http://dx.doi.org/10.1126/scitranslmed.3003960
33. Zhang L, Yang L, Li JJ, Sun L. Potential use of nucleic acid-based agents in the sensitization of nasopharyngeal carcinoma to radiotherapy. Cancer Lett 2012; 323:1-10; PMID:22484469; http://dx.doi.org/10.1016/j.canlet.2012.03.030